Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!
Hikmat Abdel-RazeqAsem MansourHazem AbdulelahAnas Al-ShwayatMohammad MakosehMohammad IbrahimMahmoud AbunasserDalia RimawiAbeer Al-RabaiahRozan AlfarAlaa' AbufaraAlaa IbrahimAnas BawalizYousef IsmaelPublished in: Thrombosis journal (2018)
Thromboembolic events in cancer patients on active cisplatin-based chemotherapy were commonly encountered. Gastric cancer, regardless of other clinical variables, was associated with the highest risk.